Association between C1431T polymorphism in peroxisome proliferator- activated receptor-γ gene and coronary artery disease in Chinese Han population

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1863-1868

  Zhou, Xiang ^a   Chen, Jianchang ^a   Xu, Weiting ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Angiography; Coronary artery disease; Peroxisome proliferator activated receptor ; Polymorphism

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRIMER DNA;

ADULT; AGE; ALLELE; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PPAR GAMMA GENE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; ASIAN; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; NONPARAMETRIC TEST; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; DNA PRIMERS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; STATISTICS, NONPARAMETRIC;

EID: 84860350795     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0931-y     Document Type: Article

References (24)

1. Issemann I, Green S (1999) Activation of a number of the steroid receptor superfamily by peroxisome. Nature 347:645-650
2. Varga T, Nagy L (2008) Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma. Eur J Clin Invest 38: 695-707
3. Beamer BA, Negri C, Yen CJ et al (1997) Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene. Biochem Biophys Res Commun 233:756-759 (Pubitemid 27217726)
4. Fajas L, Auboeuf D, Raspé E et al (1997) The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272:18779-18789 (Pubitemid 27318225)
5. Fajas L, Fruchart JC, Auwerx J (1998) PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett 438:55-60 (Pubitemid 28517834)
6. Sundvold H, Lien S (2001) Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1. Biochem Biophys Res Commun 287:383-390 (Pubitemid 32917609)
7. Vigouroux C, Fajas L, Khallouf E et al (1998) Human peroxi-some proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes 47: 490-492 (Pubitemid 28104216)
8. Deeb SS, Fajas L, Nemoto M et al (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287 (Pubitemid 28507675)
9. Savage DB, Tan GD, Acerini CL et al (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptorgamma. Diabetes 52:910-917 (Pubitemid 36384259)
10. Zaman AG, Helft G, Worthley SG, Badimon JJ (2000) The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 149:251-266 (Pubitemid 30145535)
11. Marx N, Sukhova GM, Murphy C, Libby P, Plutzky J (1998) Macrophages in human atheroma contain PPARgamma: Differentiation-dependent PPARgamma expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol 153:17-23 (Pubitemid 28317502)
12. Buzzetti R, Petrone A, Caiazzo AM et al (2005) PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr Res 57:138-140 (Pubitemid 40039904)
13. Moffett SP, Feingold E, Barmada MM et al (2005) The C161-[T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated receptor gamma. Metabolism 54:1552-1556 (Pubitemid 41527029)
14. Tai ES, Corella D, Deurenberg-Yap M et al (2004) Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res 45:485-674
15. Wang XL, Oosterhof J, Duarte N (1999) Peroxisome proliferator-activated receptor gamma C161 ? T polymorphism and coronary artery disease. Cardiovasc Res 44:588-594 (Pubitemid 30012062)
16. Doney AS, Fischer B, Leese G, Morris AD, Palmer CN (2004) Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler Thromb Vasc Biol 24:2403-2407 (Pubitemid 39658049)
17. Santamore WP, Kahl FR, Kutcher MA et al (1988) A microcomputer based automated, quantitative coronary angiographic analysis system. Ann Biomed Eng 16:367-377
18. Favis R, Day JP, Gerry NP et al (2000) Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 18:561-564 (Pubitemid 30313972)
19. Xiao Z, Xiao J, Jiang Y et al (2006) A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol Res 34:150-155
20. Sanada K, Iemitsu M, Murakami H et al (2011) PPARc2 C1431T genotype increases metabolic syndrome risk in young men with low cardiorespiratory fitness. Physiol Genom 43:103-109
21. Lagou V, Scott RA, Manios Y et al (2008) Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS study. Obesity (Silver Spring) 16:913-918 (Pubitemid 351465655)
22. Yang LL, Hua Q, Liu RK, Yang Z (2009) Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population. Arch Med Res 40:89-96
23. Doney A, Fischer B, Frew D et al (2002) Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 3:21
24. Parmley WW (1989) Prevalence and clinical significance of silent myocardial ischemia. Circulation 80:IV68-IV73